degarelix antagonist protocol
Showing 1 - 25 of >10,000
Prostatic Hyperplasia, Prostate Cancer Trial in Turku (Prostate hyperplasia medication, LhRH-antagonist)
Recruiting
- Prostatic Hyperplasia
- Prostate Cancer
- Prostate hyperplasia medication
- LhRH-antagonist
-
Turku, Finland
- +1 more
Aug 17, 2023
Invasive Ductal Breast Carcinoma Trial in Clamart (Degarelix injection(s))
Completed
- Invasive Ductal Breast Carcinoma
- Degarelix injection(s)
-
Clamart, FranceHôpital Antoine Béclère
Sep 26, 2022
Polycystic Ovary Syndrome, Infertility, IVF Trial (Progesterone antagonist, conventional antagonist protocol)
Not yet recruiting
- Polycystic Ovary Syndrome
- +2 more
- Progesterone antagonist
- conventional antagonist protocol
- (no location specified)
Apr 27, 2023
Diminished Ovarian Reserve Trial (Dydrogesterone priming ovarian stiumulation protocol, GnRH antagonist protocol)
Not yet recruiting
- Diminished Ovarian Reserve
- Dydrogesterone priming ovarian stiumulation protocol
- GnRH antagonist protocol
- (no location specified)
Apr 26, 2023
Infertility Trial in Jinan (Double Stimulation Protocol, Antagonist Stimulation Protocol)
Not yet recruiting
- Infertility
- Double Stimulation Protocol
- Antagonist Stimulation Protocol
-
Jinan, Shandong, ChinaShandong University
Mar 12, 2023
Ovary Cyst, Fertility Issues Trial in Zagazig (progestin primed ovarian stimulation protocol, dydrogesterone (Duphaston,
Recruiting
- Ovary Cyst
- Fertility Issues
- progestin primed ovarian stimulation protocol
- +2 more
-
Zagazig, EgyptZagazig University
Mar 1, 2023
IVF, PCO Trial in Bani Suwayf (Dydrogesterone Tablets, Cetrorelix)
Not yet recruiting
- IVF
- PCO
- Dydrogesterone Tablets
- Cetrorelix
-
Banī Suwayf, Beni Suef, EgyptBeni-suef university Hospital
Jul 16, 2023
SMART Protocol vs Antagonist Protocol in IVF
Active, not recruiting
- Diminished Ovarian Reserve
-
Montreal, Quebec, CanadaClinique Ovo
Dec 22, 2022
Infertility Trial in Xi'an (Biosimilar cetrorelix acetate, Reference cetrorelix acetate)
Not yet recruiting
- Infertility
- Biosimilar cetrorelix acetate
- Reference cetrorelix acetate
-
Xi'an, None Selected, ChinaHe Cai
Sep 7, 2023
Prostate Cancer Trial in United States (Abiraterone acetate, Abiraterone acetate plus degarelix, Degarelix)
Completed
- Prostate Cancer
- Abiraterone acetate
- +2 more
-
Chicago, Illinois
- +15 more
Oct 25, 2021
Premature Luteinisation, Progesterone Elevation Trial (GnRH antagonist)
Not yet recruiting
- Premature Luteinisation
- Progesterone Elevation
- GnRH antagonist
- (no location specified)
Mar 8, 2023
POSEIDON Group 3 and Group 4 as Regards IVF
Enrolling by invitation
- Infertility, Female
- IVF
- Antagonist protocol for induction of ovulation
-
Cairo, EgyptAin Shams University
Mar 19, 2023
Obesity, Fertility Trial in Aurora (Degarelix (GnRH antagonist), recombinant FSH, Cetrorelix)
Completed
- Obesity
- Fertility
- Degarelix (GnRH antagonist)
- +2 more
-
Aurora, ColoradoUniversity of Colorado Clinical and Translational Research Cente
Mar 15, 2022
IVF, GnRH Antagonist, PPOS Trial in Shanghai (Progesterone, GnRH Antagonist)
Recruiting
- IVF
- +2 more
- Progesterone
- GnRH Antagonist
-
Shanghai, ChinaShangHai JIAI Genetics&IVF Institute
Mar 28, 2022
Menopause, Obesity, Abdominal, Aging Trial in Aurora (GnRH antagonist, Estrogen Product, Placebo estradiol)
Recruiting
- Menopause
- +3 more
- GnRH antagonist
- +3 more
-
Aurora, ColoradoUniversity of Colorado - Anschutz Medical Campus
Oct 19, 2022
Preimplantation Genetic Testing, Progestin-primed Ovarian Stimulation, Euploid Rate Trial in Shanghai (GnRH antagonist, oral
Recruiting
- Preimplantation Genetic Testing
- +3 more
- GnRH antagonist
- oral Duphaston
-
Shanghai, Shanghai, ChinaShanghai JiAi Genetics & IVF Institute
Mar 28, 2022
Preimplantation Genetic Testing, Progestin-primed Ovarian Stimulation, Polycystic Ovarian Syndrome Trial (GnRH antagonist, MPA)
Not yet recruiting
- Preimplantation Genetic Testing
- +3 more
- GnRH antagonist
- MPA
- (no location specified)
Apr 9, 2022
Infertility, Female Trial in Worldwide (FE 999049 + GnRH agonist (GONAPEPTYL), FE 999049 + GnRH antagonist (CETROTIDE))
Completed
- Infertility, Female
- FE 999049 + GnRH agonist (GONAPEPTYL)
- FE 999049 + GnRH antagonist (CETROTIDE)
-
Dobl, Austria
- +15 more
Sep 28, 2022
Infertility, ART Trial in Shanghai (Duphaston, Cetrorelix)
Recruiting
- Infertility
- ART
-
Shanghai, ChinaShangHai JIAI Genetics&IVF Institute
Mar 28, 2022
Ovarian Stimulation Trial in Shibin Al Kawm (Letrozole 2.5mg tablet)
Recruiting
- Ovarian Stimulation
- Letrozole 2.5mg tablet
-
Shibīn Al Kawm, Menoufia, EgyptMenoufia University hospital
Dec 8, 2021
Menopause, Estrogen Deficiency, Women Trial in Aurora (GnRH antagonist)
Recruiting
- Menopause
- +3 more
- GnRH antagonist
-
Aurora, ColoradoUniversity of Colorado Denver Anschutz Medical Campus
Jun 9, 2022
Infertility, Female Trial in Alexandria (Duphaston, Gonadotropin, Cetrotide Injectable Product)
Completed
- Infertility, Female
- Duphaston
- +7 more
-
Alexandria, EgyptElshatby University Maternity Hospital
Jan 26, 2022
PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries Trial (Dydrogesterone Tablets, cetrorelix 0.25mg, human menopausal
Not yet recruiting
- PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries
- Dydrogesterone Tablets
- +6 more
- (no location specified)
Nov 6, 2021